Revista Brasileira de Epidemiologia (Brazilian Journal of Epidemiology) - BJE (Rev. bras. epidemiol.) - every four months, journal published by the ABRASCO - aims at publishing not previously published Original Articles, including critical reviews on specific themes, which may contribute to the development of Epidemiology and related Sciences.
Revista also publishes articles in the following categories: Debate aimed at discussing different views of the same theme which may be presented as an original article followed by comments from other authors, reproduction of panels and other similar formats; Brief communications: short reports of the original research results, besides news on events held in the field, book reviews, and others; Letters to the Editor - comments from readers on articles published in Revista Brasileira de Epidemiologia.
Its abbreviated title is Rev. bras. epidemiol., and it should be used in bibliographies, footnotes, references and bibliographic strips.
The articles published in Revista Brasileira de Epidemiologia (Brazilian Journal of Epidemiology) are indexed or summarized by:
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
Associação Brasileira de Saúde Coletiva (ABRASCO)
Faculdade de Saúde Pública / Universidade de São Paulo (FSP/USP)
Secretaria de Vigilância em Saúde (SVS) e Ministério da Saúde (MS)
Organização Pan-Americana da Saúde (OMS/OPAS)
The Revista Brasileira de Epidemiologia (RBE) [Brazilian Journal of Epidemiology]aims to publishing original and new articles that contribute to the improvement of knowledge and development of Epidemiology and related sciences.
The RBE receives manuscripts in the following categories:
The words count includes Introduction, Methods, Results, and Discussion (title page, abstract, resumo, references, tables, and figures are not included in this count).
The presented manuscripts should be solely directed to the RBE, and its simultaneous presentation in another journal is not allowed. Information and concepts present in the articles, as well as the veracity of research content, are the authors’ entire responsibility.
Articles published by the RBE are under the BY-CC Creative Commons license. Thus, the copy, adjustment, remixing, and redistribution of the material in any format and by any means, clearly indicating the eventual performed changes, is allowed. Authorship and publication credits should be properly presented, as well as the license link. When the authors publish their article in the RBE, they transfer their copyrights to the journal and grant it with the first publication right.
Each manuscript is assessed by at least two assessors designated by one of the Associated Editors (AE). The AE will be in charge of elaborating a conclusive final report to be submitted to the Editor-in-chief. In the first stage of submission, the editorial office will check if all the criteria of standards were met. The manuscript will only be sent to the AE’s assessment after complying with all the standard established by RBE.
The Brazilian Journal of Epidemiology does not charge fees for the submission of papers, nor to evaluate or publish them.
Approval by the Ethics Committee in Research (CEP)
All papers submitted to the RBE must have followed the recommendations of ethics in research of Declaration of Helsinki and the standards contained in the Resolutions No. 466/2012 and 510/2016 from the Brazilian Health Office (CNS, acronym in Portuguese). The approval by an Ethics Committee in Research (CEP, acronym in Portuguese) is not required for studies that analyze added data and data without people’s identification, such as those available in public domain databases. No instance is above the CEP to analyze the nature of investigation proposals, following the orientation of the Brazilian Commission of Ethics in Research, CNS, Brazilian Department of Health (CONEP/CNS/MS). The CEP that approves the investigation should be registered at the CONEP.
Submission of the CEP protocol copy is mandatory at the submission.
The RBE supports the policies from the World Health Organization (WHO) and International Committee of Medical Journal Editors (ICMJE) for registration of clinical trials. Thus, it recognizes the importance of these initiatives for international registration and disclosure of open-access information. Therefore, only articles of clinical trials that have received an identification number in one of the clinical trials validated for the criteria established by the WHO and ICMJE, whose addresses are available at the ICMJE website, are accepted for publication. The identification/approval number should be registered in the title page.
The entities that register clinical trials according to ICMJE criteria are:
For definition of article authorship, the RBE follows the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals elaborated by the International Committee of Medical Journal Editors (ICMJE). The authors should follow the guidelines available at http://www.icmje.org/, translated into Portuguese in the article made by Duarte and Pansani (2015), available at https://doi.org/10.5123/S1679-49742015000300025.
Conflict of interests
All authors should manifest the existence or absence of conflicts of interests during the study conduction. Conflicts of interests may happen when authors or institutions have any sort of relations with organizations or individuals that may influence the study at issue. Examples of conflicts of interests include professional bond, consultant service provision, financing or any other kind of financial support received, shareholder participation in companies, patent possession, and received tributes. In the event of no conflict of interests, the authors should declare: “The authors report the non-existence of any kind of conflict of interests.”
The information regarding conflicts of interests should be added in the title page.
All authors shall agree and sign the statement of conflict of interests, the statement of copyrights, and the nonsolicitation statement.
Additional materials that contribute to better understand the article may be submitted by the authors. These files will be available online and should be mentioned in the text body. However, this material will not be incorporated in the article designing, and it will be published as received. If the manuscript is approved for publication, the complementary documents will not be proofread, standardized, designed or translated. Each complementary file shall have a title describing it. The authors shall transfer the files in PDF with the option Supplemental File for Review. The content of these files should not be added in the end of the manuscript. All of them should be clear enough to allow their reproduction, and the images shall be provided in high resolution.
Manuscripts are accepted in Portuguese, Spanish or English. Articles in Portuguese and Spanish shall be followed by an an abstract in the original text language, besides an abstract written in English. The articles in English shall be followed by the abstract, besides the abstract written in Portuguese.
The manuscripts shall mandatorily present the following structure, in an only file:
- Title Page
The title page shall include:
In the following pages, always beginning in a new page, the following sections should be presented:
The main study results and innovations should be presented in three to four points (bullets). Ninety characters is the maximum amount to be used, including spaces, per point. The highlights should be dedicated to the study results, prioritizing the most relevant and/or original outcomes. We recommend the first point to highlight, if there is, any innovative methodological aspect. Do not add any aspect originated in the Introduction and/or Discussion sections in these bullets. Be objective, privilege the main article points. The abstract and article will bring more information of the results. The submission of “Highlights” shall occur only in original articles and review/metanalysis articles.
Abstracts shall have 250 words at most and shall be presented in the structured form, including the sections: Objective, Methods, Results, and Conclusion. The same rules are applied to the to resumo.
The authorsshall present at least four and at most six keywords, in the language in which the manuscript was presented and in English. These keywords should be standardized according to the Health Sciences Descriptors (DeCS, acronym in Portuguese), available at http://decs.bvs.br/.
The last paragraph(s) of the Discussion is(are) recommended to be focused on the conclusions and recommendations.
They should be numbered according to the first time it is mention in the text, using superscripted Arabic algorisms. The final list shall follow the text number order and ignore the authors’ alphabetical order of the authors. Titles of books, publishers or others should not be abbreviated. Titles of journals shall follow the abbreviations in the Index Medicus/Medline Index. They should include the names of the first six authors; but if there are more than six authors, the expression et al. must come after the names. Whenever it is available, the digital object identifier (DOI) shall be reported in the end of the reference, based on the following example. Personal communications, new or ongoing papers may be quoted when completely required, but they should not be included in the list of references. They should only be presented in the text body or in a footnote. When an article is still going to be published, the journal title, year and other available data should be provided, followed by the expression "In press” in parenthesis. The accuracy of the references is the authors’ responsibility.
EXAMPLES OF REFERENCES
Barros AJ, Victora CG. Measuring coverage in MNCH: determining and interpreting inequalities in coverage of maternal, newborn, and child health interventions. PLoS Med 2013; 10: e1001390. https://doi.org/10.1371/journal.pmed.1001390
Books and other monographs
Congress paper or similar (published)
Report of the World Health Organization
Figures and tables
Tables and figures (graphs, maps, and drawings) should be added in the end of the manuscript, but their submission in separate files is not allowed. The titles should be provided in the language in which the article was presented. There must be a page break between each of them. Five pages is the maximum amount allowed for tables and figures. Do not format tables using the TAB key; use the table tool of the text editor program.
All the article content (title page, resumos, abstract, introduction, method, results, discussion, bibliographic references, and illustrations) shall be presented in Times New Roman font, size 12 and double subtext space. Do not use line breaks. Do not use forced manual hyphenations.
The full final file (title page, sections, references, and illustrations) shall be submitted only in the DOC format (Microsoft Word).
When abbreviations are mentioned for the first time in the text, they should follow the unabbreviated term. Do not use abbreviations in the titles and abstract
Manuscripts are submitted online, using the SciELO platform (https://mc04.manuscriptcentral.com/rbepid-scielo).
There is no fee for submission and review articles.